Innate Pharma (IPHA) Total Debt (2017 - 2026)
Innate Pharma (IPHA) posted Total Debt of $23.49 million for the quarter ended Jun 30, 2026, down 23.2% from $30.6 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Total Debt (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma's Total Debt came in at $25.5 million, down 24.0% from the prior year.
- Annual Total Debt shows a five-year compound annual growth rate of 3.2% (years ended Dec 2020 to Dec 2025).
- In prior years, Innate Pharma's Total Debt was $33.55 million in the year ended Dec 31, 2024 (-36.5%), $52.82 million in the year ended Dec 31, 2023 (+13.0%), $46.75 million in the year ended Dec 31, 2022 (-7.7%) and $50.62 million in the year ended Dec 31, 2021 (+132.3%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Total Debt since the quarter ended Jun 30, 2021.
- The strongest year-over-year quarter for Total Debt in the past five years was the quarter ended Jun 30, 2022, with growth of 132.9%; the weakest was the quarter ended Jun 30, 2026, with a decline of 23.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 54.91 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 49.04 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 70.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 53.91 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.59 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 32.35 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 57.30 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 26.25 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 63.19 Bn |
| 10 | Innate Pharma | 143.35 Mn | -63.85 Mn | - | 12.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.67 Mn |
| Dec 31, 2025 | 20.26 Mn |
| Jun 30, 2025 | 22.52 Mn |
| Dec 31, 2024 | 23.48 Mn |
| Jun 30, 2024 | 28.86 Mn |
| Dec 31, 2023 | 34.93 Mn |
| Jun 30, 2023 | 40.29 Mn |
| Dec 31, 2022 | 44.45 Mn |
| Jun 30, 2022 | 13.90 Mn |
| Dec 31, 2021 | 16.02 Mn |
| Jun 30, 2021 | 23.93 Mn |
| Dec 31, 2020 | 21.67 Mn |
| Jun 30, 2020 | 19.17 Mn |
| Dec 31, 2019 | 18.75 Mn |
| Dec 31, 2018 | 3.68 Mn |
| Dec 31, 2017 | 6.61 Mn |
API Access
Innate Pharma Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();